Cytoplasmic Localization of RXRα Determines Outcome in Breast Cancer (original) (raw)
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients
Vincent Cavailles
Cells
View PDFchevron_right
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Vincent Cavailles
Journal of Cancer Research and Clinical Oncology
View PDFchevron_right
Nuclear and cytoplasmic expression of ER$beta$1, ER$beta$2, and ER$beta$5 identifies distinct prognostic outcome for breast cancer patients
T Hughes
View PDFchevron_right
Research Resource: Nuclear Receptors as Transcriptome: Discriminant and Prognostic Value in Breast Cancer
Evan Simpson
Molecular Endocrinology, 2013
View PDFchevron_right
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
Simak Ali
British Journal of Cancer, 2019
View PDFchevron_right
A Shift from Nuclear to Cytoplasmic Breast Cancer Metastasis Suppressor 1 Expression Is Associated with Highly Proliferative Estrogen Receptor-Negative Breast Cancers
Robert Seitz
Tumor Biology, 2009
View PDFchevron_right
Nuclear and Cytoplasmic Expression of ER 1, ER 2, and ER 5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
Philippa Saunders
Clinical Cancer Research, 2008
View PDFchevron_right
Study on Histopathological Correlation with ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and its Prognostic Importance
SSR Institute of International Journal of Life Sciences
SSR Institute of International Journal of Life Sciences, 2019
View PDFchevron_right
RhoA protein expression in primary breast cancers and matched lymphocytes is associated with progression of the disease
Stephan Reshkin
International Journal of Molecular Medicine, 2008
View PDFchevron_right
The favourable prognostic value of oestrogen receptor immunohistochemical expression in breast cancer
Andreas C . Lazaris
Journal of Clinical Pathology, 2004
View PDFchevron_right
ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
Rafał Matkowski
Cellular Oncology, 2013
View PDFchevron_right
CXCL12 postively correlates with disease free survival in breast cancer
Valentina Mirisola
View PDFchevron_right
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
Andrew Teschendorff
Oncotarget, 2015
View PDFchevron_right
CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of disease-free and overall survival
Ulrich Pfeffer
European Journal of Cancer, 2009
View PDFchevron_right
Molecular and clinicopathological markers of prognosis in breast cancer
Kyle Matchett
Expert Review of Molecular Diagnostics, 2013
View PDFchevron_right
Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis
massimo gion
Breast Cancer Research and Treatment, 2000
View PDFchevron_right
Prognostic Biomarkers in Breast Cancer: Factors Affecting Immunohistochemical Evaluation
William Grizzle
The Breast Journal, 1995
View PDFchevron_right
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer
Craig Allred
Breast Cancer Research and Treatment, 2010
View PDFchevron_right
RAB6C is an independent prognostic factor of estrogen receptor‑positive/progesterone receptor‑negative breast cancer
Olle Stål
Oncology Letters
View PDFchevron_right
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
Rezvan Faisal Abduljabbar
Breast Cancer Research and Treatment, 2016
View PDFchevron_right
Measures of Cell Turnover (Proliferation and Apoptosis) and Their Association with Survival in Breast Cancer
Ann Thor
Clinical Cancer Research, 2001
View PDFchevron_right
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer
Signe Borgquist
Modern Pathology, 2009
View PDFchevron_right
RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer
Fred Inserm, Per Lønning
Annals of Oncology, 2011
View PDFchevron_right
Developmental protein HOXC11 cooperates with SRC-1 in breast cancer: an adaptive response to endocrine therapy
D. McCartan
Breast Cancer Research, 2010
View PDFchevron_right
DC-SCRIPT: Nuclear Receptor Modulation and Prognostic Significance in Primary Breast Cancer
S. Hontelez, Marleen Ansems
View PDFchevron_right
Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy
Monica Verrico
Cancer Chemotherapy and Pharmacology, 2019
View PDFchevron_right
AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast Tumors
Nelson Rangel
Cells
View PDFchevron_right
ERRα is a marker of tamoxifen response and survival in triple-negative breast cancer
Elin Lager
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015
View PDFchevron_right
Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression
Eleni Timotheadou
2012
View PDFchevron_right
Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis
Wen Jiang
Anticancer research, 2011
View PDFchevron_right
A prospective analysis of immunohistochemically determined hormone receptors and nuclear features as predictors of early recurrence in primary breast cancer
Renate Weber
Breast Cancer Research and Treatment, 1995
View PDFchevron_right